Diabetes Technologies that never took off. Whatever happened to the “Sprinkler Needle”?
One of the biggest difficulties people with Diabetes have with MDI is timing insulin delivery. This isn’t helped by advice received from HCPs which tends […]
One of the biggest difficulties people with Diabetes have with MDI is timing insulin delivery. This isn’t helped by advice received from HCPs which tends […]
I’ve written about the various curveballs that Fiasp has thrown at me on multiple occasions, and for the past few weeks I’ve continued to observe […]
Back in 2013, in the US, Medtronic launched the 530G pump, and everyone and his dog called it an artificial pancreas. As Scott Hanselmann stated […]
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
If there’s one thing I’ve learned from my experiences with Fiasp over the past month or so, it’s how important access to my data […]
So then. 10 days after switching back to Novorapid because I was having a devil of a time with the Fiasp, I received a new […]
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]
Whilst I was more or less forced to swap off Fiasp a week or so ago, I thought it might be interesting to take a […]
oref1 has been in the wild in master since the release of 0.5.0 of OpenAPS, introducing the ability to Super-Micro Bolus (SMB) which delivers small […]
Six months down the line, you’d think that everything was settled and stable. At least, that’s what I’d expect. And then that not so shiny […]
Copyright © 2025 | WordPress Theme by MH Themes